Inogen Inc
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregis tered Sales of Equity Securities and Use of Proceeds
Unregistered sales of equity securities
Not applicable.
Issuer purchases of equity securities
The following table provides information about purchases by us of our common stock during the three months ended September 30, 2026:
| (amounts in thousands) | ||||
|---|---|---|---|---|
| Period | Total number of shares purchased (1) | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs (2) | Approximate dollar value of shares that may yet be purchased under the plans or programs |
| July 1, 2026 through July 31, 2026 | 192,100 | $6.50 | 192,100 | $21,300 |
| August 1, 2026 through August 31, 2026 | 212,600 | 5.88 | 212,600 | 20,000 |
| September 1, 2026 through September 30, 2026 | 237,000 | 5.27 | 237,000 | 18,800 |
| Total | 641,700 | $5.84 | 641,700 | $18,800 |
(1) In February 2026, our Board of Directors authorized a share repurchase program under which we may repurchase up to $30.0 million of our outstanding common stock. The program expires on December 31, 2027, or when the maximum authorized dollar amount has been utilized, whichever occurs first. The share repurchase program does not obligate us to make any repurchases and may be modified, suspended, or terminated by us at any time without prior notice. Effective November 2, 2026, the aggregate repurchase authorization was increased to $45.0 million and the program’s expiration date was extended to June 30, 2028. All other terms of the program remain unchanged.
(2) The total number of shares purchased as part of the publicly announced program were all purchased pursuant to the February 2026 authorization.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.